NAME

HONG KONG/BEIJING, Jan 6 (Reuters) – China is in talks with Pfizer Inc. (PFE.N) to obtain a license that will allow domestic drugmakers to manufacture and distribute a generic version …

Massive tech layoffs spawn a new wave of startups Early-stage VC funding around record levels Echoes of the dotcom collapse that fueled Facebook and others Jan 3 (Reuters) – Nic …

WASHINGTON, Dec 29 (Reuters) – The US Food and Drug Administration failed to follow its own internal guidelines and practices during Biogen’s approval process. (BIIB.O) Aduhelm, the Alzheimer’s drug, was …

Thousands of Zantac Lawsuits Dismissed Tuesday The decision bodes well for pending lawsuits: analysts GSK and Sanofi rally adds more than $20 billion to combined mkt cap LONDON, Dec 7 …

CHICAGO, Nov 29 (Reuters) – The first breakthrough in 30 years of Alzheimer’s research is giving impetus to clinical trials of “cocktail” treatments that target the two distinctive proteins associated …

RALEIGH, N.C./NEW YORK, November 25 (Reuters) – With the Thanksgiving turkey digested, shoppers were expected to turn out in record numbers to shop for Black Friday deals. However, with inclement …

NEW YORK, November 23 (Reuters) – Retailers going from Walmart (WMT.N) a Barnes & Noble are installing cameras or locking items away to deter thieves and thieves as they prepare …

Best Buy rises, sees smaller annual sales decline Dollar Tree falls on lower fiscal year earnings forecast Manchester United rises after sale report Dow up 1.18%, S&P 500 up 1.36%, …

Tata plans expansion of beauty sector in latest retail bet Technological boost of Eyes with skin analyzers, virtual test in kiosks Tata targets at least 20 stores next year Company …

LONDON, Nov 9 (Reuters) – Some European retailers this week forecast or reported better sales for the full year after working to keep prices low to attract cash-strapped shoppers, while …